Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

  • E. G. Hanania
  • , R. E. Giles
  • , J. Kavanagh
  • , D. Ellerson
  • , Z. Zu
  • , T. Wang
  • , Y. Su
  • , A. Kudelka
  • , Z. Rahman
  • , F. Holmes
  • , G. Hortobagyi
  • , D. Claxton
  • , C. Bachier
  • , P. Thall
  • , S. Cheng
  • , J. Hester
  • , J. M. Ostrove
  • , R. E. Bird
  • , A. Chang
  • , M. Korbling
    • D. Seong, R. Cote, T. Holzmayer, E. Mechetner, S. Heimfeld, R. Berenson, B. Burtness, C. Edwards, R. Bast, M. Andreeff, R. Champlin, A. B. Deisseroth

Research output: Contribution to journal › Article › peer-review

145 Scopus citations

Fingerprint

Dive into the research topics of 'Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science